Table 1. Patient baseline characteristics.
| Variables | DAPT (n = 28) | MAPT (n = 29) | P-value |
| Male (%) | 20 (71.4) | 19 (65.5) | NS |
| Age (years) | 65.7 ± 8.3 | 63.2 ± 8.4 | NS |
| Smoking, n (%) | 11 (39.3) | 8 (27.6) | NS |
| Hypertension, n (%) | 18 (64.3) | 22 (76.9) | NS |
| Hyperlipidemia, n (%) | 8 (28.6) | 9 (31.0) | NS |
| Diagnosis, n (%) | |||
| UAP | 19 (67.9) | 18 (62.1) | NS |
| SAP | 4 (14.3) | 3 (10.3) | NS |
| AMI | 5 (17.9) | 6 (20.7) | NS |
| OMI | 0 (0) | 2 (6.9) | NS |
| Diabetes mellitus, n (%) | 7 (25.0) | 11 (37.9) | NS |
| LVEF (%) | 63.7 ± 3.9 | 63.2 ± 3.5 | NS |
| Serum lipid level (μmmol/L) | |||
| TC | 3.8 ± 0.8 | 3.9 ± 0.8 | NS |
| TG | 1.6 ± 0.9 | 1.5 ± 1.1 | NS |
| LDL-C | 2.5 ± 0.6 | 2.6 ± 0.7 | NS |
DAPT: dual antiplatelet treatment; MAPT: mono-antiplatelet treatment; UAP: unstable angina pectoris; SAP: stable angina pectoris; AMI: acute myocardial infarction; OMI: old myocardial infarction; LVEF: left ventricular ejection fraction; TC: total cholesterol; TG: triglyceride; LDL-C: low density lipoprotein-cholesterol; NS: no statistical significance.